慢性丙型肝炎患者直接抗病毒药物根除病毒后骨骼肌质量增加:一项纵向研究
这项纵向研究纳入62例慢性丙型肝炎门诊患者,在直接抗病毒药物(DAA)治疗前及治疗后12周和48周评估身体成分。结果显示肝纤维化标志物显著下降,骨骼肌质量指数在治疗后12周和48周分别增加0.20和0.22 kg/m²。
要点
- DAA根除HCV后肝纤维化非侵入性标志物动态下降。
- 治疗后12周和48周骨骼肌质量指数分别增加0.20和0.22 kg/m²。
- 相位角每增加1单位,计时起立行走测试时间减少0.38分钟。
核心结论
- DAA治疗根除HCV与62例慢性丙型肝炎患者肝纤维化非侵入性标志物的动态下降及肌肉质量增加相关,这些患者在抗病毒治疗结束后12周时HCV载量检测不到。
研究设计与样本
- 纵向研究,纳入62例慢性丙型肝炎门诊患者,在DAA治疗前(T0)及治疗后12周(T1)和48周(T2)进行身体成分评估。
主要发现
- 肝纤维化标志物显著下降。
- 骨骼肌质量指数在T1和T2分别增加0.20和0.22 kg/m²。
- DAA治疗后相位角每增加1单位,计时起立行走测试时间减少0.38分钟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Results of studies evaluating the effect of viral eradication following direct-acting antiviral (DDA) therapy on skeletal muscle mass of patients with chronic hepatitis C (CHC) are scarce. AIM: To assess the components of sarcopenia (low muscle mass, low muscle strength and low physical performance) in a cohort of CHC individuals before and after DAA therapy. METHODS: We performed a longitudinal study of patients with CHC who underwent body composition assessment before (T0), and at 12 (T1) and 48 (T2) weeks after DDA therapy. Bioelectrical Impedance Analysis was used to assess skeletal mass muscle (SM) and phase angle (PhA). SM index (SMI) was calculated by dividing the SM by squared height. Muscle function was evaluated by hand grip strength (HGS) and timed up-and-go (TUG) test. Mixed-effects linear regression models were fitted to SMI, HGS and physical performance and were used to test the effect of HCV eradication by DAA. RESULTS: 62 outpatients (mean age, 58.6 ± 10.8 years; 58% with compensated cirrhosis) were included. Significant decreases in liver fibrosis markers and an increase of 0.20 and 0.22 kg/m2 in the SMI were observed at T1 and T2. Following DAA therapy, an increase of one unit of PhA was associated with a reduction of 0.38 min in TUG. CONCLUSION: HCV eradication with DAA therapy was associated with a dynamic reduction of non-invasive markers of liver fibrosis and increased muscle mass in 62 patients with CHC who had an undetectable HCV load at 12 weeks after completion of antiviral treatment.
引用
- Coelho MPP, de Vries TP, Pires AM, et al. Skeletal muscle mass increases after viral eradication with direct-acting antivirals in patients with chronic hepatitis C: A longitudinal study. Aliment Pharmacol Ther. 2024. PMID: 38501893. doi:10.1111/apt.17950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。